Le Lézard
Classified in: Health

Arroyo Grande Dentist, Dr. Perry Patel, Announces Dermal Fillers Now Available For Patients


PASO ROBLES, Calif., Sept. 21, 2019 /PRNewswire-PRWeb/ -- Dr. Perry Patel, an Arroyo Grande dentist, recently announced that he has been certified by the American Academy of Facial Esthetics (AAFE) to administer dermal filler injections. Dr. Patel offers Juvederm® dermal fillers and SkinMedica® professional medical-grade skin care products.

Dr. Patel has also been certified by the AAFE to administer Botox injections to help patients get relief from a wide range of orofacial conditions that contribute to dental problems, such as tooth grinding, temporomandibular joint disorders (TMJ), and other conditions involving the tongue, jaw and the headaches that accompany these conditions.

Dermal fillers replace lost hyaluronic acid, which is the body's natural filler substance. As we age, we lose hyaluronic acid and the face starts to show this loss with deeper nasolabial folds, marionette lines, and thinning lips. Dermal fillers can be injected to replace the lost volume, creating a younger look. Dermal fillers can be used for lip augmentation, asymmetrical lips and for completing certain dentistry procedures to frame the bright new smile that comes with successful dental procedures.

Medical-grade skincare products give patients even more options for reversing the signs of aging skin. These products are designed to provide deep treatment solutions for patients with serious skin issues or concerns about fine lines and wrinkles. These products can only be purchased from medical and dental professionals who are also monitoring the effect the product is having.

The effect of dermal fillers typically last anywhere from six to 12 months and can be repeated. Botox and dermal fillers procedures take anywhere from five to 15 minutes.

Why see a dentist for dermal fillers? Because:

The application of Botox in dentistry has increased to help treat physical and cosmetic conditions and may be an alternative when other treatments have failed. Botox can be used in a dental office as part of a comprehensive treatment plan for a wide range of issues such as tooth clenching and grinding, tongue tension, temporomandibular joint disorders, commonly referred to as TMJ, and other disorders that involve chewing, the tongue, ability to open and close the jaw and the headaches that accompany these conditions.

The American Academy of Facial Esthetics is a professional healthcare organization with the mission to teach the best non-surgical and non-invasive facial injectable techniques to healthcare professionals worldwide. The AAFE is comprised of physicians, dentists, nurses and other healthcare professionals committed to providing the best possible outcomes in areas of facial esthetics and facial pain treatment.

Dr. Perry Patel provides dental care for all needs from children to senior citizens. Services include emergency dental care, check-ups and cleanings, general dentistry and advanced dental care. Dr. Patel has a professional passion for dental and facial esthetics and performs all Botox and dermal filler injections himself. His office provides Netflix for viewing during appointments and we use Nitrous Oxide Gas, often referred to as laughing gas, as an effective anesthetic during dental treatments.

Dr. Perry Patel
901 N Oak Park Boulevard #103
Pismo Beach, CA 93449
(805) 489-4761

This press release is by Paso Robles online marketing company Access Publishing, 806 9th Street, #2D, Paso Robles, CA 93446. (805) 226-9890.

 

SOURCE Dr. Perry Patel


These press releases may also interest you

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:24
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United States. Concurrently, the identical INSPiRE-ICU 2 trial is nearing completion, with 23 of 235...



News published on and distributed by: